Members of Stevens & Bolton's Life Sciences team, Charlotte Tillett, Head of Life Sciences and Beverley Flynn, Partner will be attending the 12th EGA Legal Affairs Conference in Brussels from 8 - 9 March 2016.
The Conference will encompass interactive discussion between leading industry experts, in-house counsels and European Commission officials on the latest legal and IP developments regarding generic and biosimilar medicines in Europe and worldwide. Topics will include:
- High level discussion: today’s environment, the opportunities & challenges of tomorrow
- IP & Competition: how to stimulate growth
- Legal and IP considerations for regulatory and market dynamics
- Developments in IP for Biosimilars
- The industry’s international IP & legal perspective
- In-depth discussion on UPC
Stevens & Bolton has a specialist team of Life Sciences lawyers, many of whom have worked within the industry and have relevant technical backgrounds. We pride ourselves in providing responsive, commercial and above all high quality advice.
As a consequence, we are instructed by some of the world’s largest pharmaceutical and biotechnology companies, universities, medical device manufacturers, clinical services providers, regulatory services providers and financial institutions with an interest in the sector.
If you are attending the conference, and would like to arrange a meeting please contact Charlotte Tillett: firstname.lastname@example.org or Beverley Flynn: email@example.com
To find out more about the EGA Legal Affairs Conference, please visit: http://www.egaevents.org/lac/